Imaging the extracellular pH of tumors by MRI after injection of a single cocktail of T 1 and T 2 contrast agents

NMR in Biomedicine

Volumn 24, Issue 10, 2011, Pages 1380-1391

  Martinez, Gary V ^a   Zhang, Xiaomeng ^b   García Martín, María L ^c   Morse, David L ^a   Woods, Mark ^d   Sherry, A Dean ^d,e   Gillies, Robert J ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF MÁLAGA   (Spain)

^d UNIVERSITY OF TEXAS AT DALLAS   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Cocktail; Contrast agent; PH; Susceptibility

Indexed keywords

ACIDIC PH; COCKTAIL; CONCENTRATION DETERMINATION; CONTRAST AGENT; ECHO-PLANAR SPECTROSCOPIC IMAGING; EXTRACELLULAR PH; GD-DTPA; HIGH SPATIAL RESOLUTION; IN-VIVO; INVASIVENESS; LINEAR RELATIONSHIPS; NON-LINEARITY; RAT BRAIN; RELAXATION RATE CONSTANT; RELAXIVITY; SOLID TUMORS; SPIN LATTICES; SPIN-SPIN RELAXIVITY; TETRAKIS; VASCULAR PERMEABILITY;

CALIBRATION; DYSPROSIUM; GADOLINIUM; MAGNETIC RESONANCE IMAGING; MAGNETIC SUSCEPTIBILITY; PH; RATE CONSTANTS; SPHERES; TUMORS;

PH EFFECTS;

DYSPROSIUM; DYSPROSIUM 1,4,7,10 TETRAAZACYCLODODECANE N,N',N'',N''' TETRAKIS(METHYLENEPHOSPHONIC ACID); GADOLINIUM; GADOLINIUM 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAAMINOPHOSPHONATE; GADOLINIUM PENTETATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CALIBRATION; CONCENTRATION (PARAMETERS); CRYSTAL STRUCTURE; ECHO PLANAR IMAGING; ECHO PLANAR SPECTROSCOPIC IMAGING; EXTRACELLULAR PH; FEMALE; GLIOMA; IN VIVO STUDY; NONHUMAN; PH; PRIORITY JOURNAL; RAT; SPECTROSCOPY;

ANIMALS; CALIBRATION; CONTRAST MEDIA; EXTRACELLULAR SPACE; FEMALE; HYDROGEN-ION CONCENTRATION; INJECTIONS; MAGNETIC RESONANCE IMAGING; RATS; RATS, WISTAR; TIME FACTORS;

RATTUS;

EID: 80052868049     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1701     Document Type: Article

References (33)

1. Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis?Nat. Rev. Cancer, 2004;4(11):891-899.
2. Gillies RJ, Robey I, Gatenby RA. Causes and consequences of increased glucose metabolism of cancers.J. Nucl. Med. 2008;49 (Suppl 2):24S-42S.
3. Robey IF, Baggett BK, Kirkpatrick ND, Roe DJ, Dosescu J, Sloane BF, Hashim AI, Morse DL, Raghunand N, Gatenby RA, Gillies RJ. Bicarbonate increases tumor pH and inhibits spontaneous metastases. Cancer Res. 2009;69(6):2260-2268.
4. Gillies RJ, Raghunand N, Garcia-Martin ML, Gatenby RA. pH imaging. A review of pH measurement methods and applications in cancers. IEEE Eng. Med. Biol. Mag. 2004;23(5):57-64.
5. Zhang X, Lin Y, Gillies RJ. Tumor pH and its measurement.J. Nucl. Med. 2010;51(8):1167-1170.
6. Bhujwalla ZM, Artemov D, Ballesteros P, Cerdan S, Gillies RJ, Solaiyappan M. Combined vascular and extracellular pH imaging of solid tumors. NMR Biomed. 2002;15(2):114-119.
7. 13C-labelled bicarbonate. Nature, 2008;453(7197):940-943.
8. 1H magnetic resonance spectroscopic imaging: comparison with maps of metabolites. Cancer Res. 2001;61(17):6524-6531.
9. 1H MRSI. Magn. Reson. Med. 1999;41(4):743-750.
10. Mori S, Eleff SM, Pilatus U, Mori N, van Zijl PC. Proton NMR spectroscopy of solvent-saturable resonances: a new approach to study pH effects in situ. Magn. Reson. Med. 1998;40(1):36-42.
11. Zhou J, Lal B, Wilson DA, Laterra J, van Zijl PC. Amide proton transfer (APT) contrast for imaging of brain tumors. Magn. Reson. Med. 2003;50(6):1120-1126.
12. Zhou J, Payen JF, Wilson DA, Traystman RJ, van Zijl PC. Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nat. Med. 2003;9(8):1085-1090.
13. Kalman FK, Woods M, Caravan P, Jurek P, Spiller M, Tircso G, Kiraly R, Brucher E, Sherry AD. Potentiometric and relaxometric properties of a gadolinium-based MRI contrast agent for sensing tissue pH. Inorg. Chem. 2007;46(13):5260-5270.
14. Garcia-Martin ML, Martinez GV, Raghunand N, Sherry AD, Zhang S, Gillies RJ. High resolution pH(e) imaging of rat glioma using pH-dependent relaxivity. Magn. Reson. Med. 2006;55(2):309-315.
15. Raghunand N, Howison C, Sherry AD, Zhang S, Gillies RJ. Renal and systemic pH imaging by contrast-enhanced MRI. Magn. Reson. Med. 2003;49(2):249-257.
16. Cron GO, Wallace JC, Stevens WD, Fortin T, Pappas BA, Wilkins RC, Kelcz F, Santyr GE.A comparison of T2*-weighted magnitude and phase imaging for measuring the arterial input function in the rat aorta following intravenous injection of gadolinium contrast agent. Magn. Reson. Imaging, 2005;23(5):619-627.
17. Dimicoli JL, Patry J, Poupon J, Volk A. On the use of R1 and R2* for measurement of contrast agent concentration in isolated perfused rat liver. NMR Biomed. 2003;16(5):276-285.
18. van Osch MJ, Vonken EJ, Viergever MA, van der Grond J, Bakker CJ. Measuring the arterial input function with gradient echo sequences. Magn. Reson. Med. 2003;49(6):1067-1076.
19. Chu A, Alger JR, Moore GJ, Posse S. Proton echo-planar spectroscopic imaging with highly effective outer volume suppression using combined presaturation and spatially selective echo dephasing. Magn. Reson. Med. 2003;49(5):817-821.
20. Posse S, DeCarli C, Le Bihan D. Three-dimensional echo-planar MR spectroscopic imaging at short echo times in the human brain. Radiology, 1994;192(3):733-738.
21. 1H spectroscopic imaging in human brain by echo planar spatial-spectral encoding. Magn. Reson. Med. 1995;33(1):34-40.
22. Du W, Fan X, Foxley S, Zamora M, River JN, Culp RM, Karczmar GS. Comparison of high-resolution echo-planar spectroscopic imaging with conventional MR imaging of prostate tumors in mice. NMR Biomed. 2005;18(5):285-292.
23. Du W, Karczmar GS, Uftring SJ, Du YP. Anatomical and functional brain imaging using high-resolution echo-planar spectroscopic imaging at 1.5 Tesla. NMR Biomed. 2005;18(4):235-241.
24. Sarkar S, Heberlein K, Metzger GJ, Zhang X, Hu X. Applications of high-resolution echoplanar spectroscopic imaging for structural imaging.J. Magn. Reson. Imaging, 1999;10(1):1-7.
25. Zhang S, Wu K, Sherry AD.A Novel pH-sensitive MRI contrast agent. Angew. Chem. Int. Ed. Engl. 1999;38(21):3192-3194.
26. Nelson SJ, Vigneron DB, Star-Lack J, Kurhanewicz J. High spatial resolution and speed in MRSI. NMR Biomed. 1997;10(8):411-422.
27. Yablonskiy DA. Quantitation of intrinsic magnetic susceptibility-related effects in a tissue matrix. Phantom study. Magn. Reson. Med. 1998;39(3):417-428.
28. Yablonskiy DA, Haacke EM. Theory of NMR signal behavior in magnetically inhomogeneous tissues: the static dephasing regime. Magn. Reson. Med. 1994;32(6):749-763.
29. Bevington P, Robinson D. Data Reduction and Error Analysis for the Physical Sciences. McGraw-Hill: Boston, Massachusetts;1992.
30. Pike MM, Stoops CN, Langford CP, Akella NS, Nabors LB, Gillespie GY. High-resolution longitudinal assessment of flow and permeability in mouse glioma vasculature: sequential small molecule and SPIO dynamic contrast agent MRI. Magn. Reson. Med. 2009;61(3):615-625.
31. Vincensini D, Dedieu V, Renou JP, Otal P, Joffre F. Measurements of extracellular volume fraction and capillary permeability in tissues using dynamic spin-lattice relaxometry: studies in rabbit muscles. Magn. Reson. Imaging, 2003;21(2):85-93.
32. Landis CS, Li X, Telang FW, Molina PE, Palyka I, Vetek G, Springer CS Jr. Equilibrium transcytolemmal water-exchange kinetics in skeletal muscle in vivo. Magn. Reson. Med. 1999;42(3):467-478.
33. Yankeelov TE, Rooney WD, Li X, Springer CS Jr. Variation of the relaxographic 'shutter-speed' for transcytolemmal water exchange affects the CR bolus-tracking curve shape. Magn. Reson. Med. 2003;50(6):1151-1169.